financetom
Business
financetom
/
Business
/
--Mueller Industries to Pay Quarterly Dividend at $0.20 Per Share, Payable June 21 to Shareholders on June 7
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Mueller Industries to Pay Quarterly Dividend at $0.20 Per Share, Payable June 21 to Shareholders on June 7
May 10, 2024 1:45 PM

04:08 PM EDT, 05/10/2024 (MT Newswires) --

Price: 60.00, Change: +0.69, Percent Change: +1.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nurix Therapeutics, Gilead Sciences Extend Research Collaboration By 2 Years
Nurix Therapeutics, Gilead Sciences Extend Research Collaboration By 2 Years
Apr 2, 2024
09:23 AM EDT, 04/02/2024 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Tuesday that Gilead Sciences ( GILD ) has extended their research collaboration for an additional two years to develop more clinical candidates. Under the terms of the partnership, first signed in 2019, Nurix employs its drug discovery platform to find agents targeting drug degradation via E3 ligases,...
Update: Tesla's 386,810 Q1 Deliveries Significantly Miss Wall Street Estimates
Update: Tesla's 386,810 Q1 Deliveries Significantly Miss Wall Street Estimates
Apr 2, 2024
09:27 AM EDT, 04/02/2024 (MT Newswires) -- (Updates with additional details and the latest stock movement.) Tesla (TSLA) had 386,810 Q1 deliveries, significantly missing the Bloomberg Consensus estimate of 449,080. The company manufactured 433,371 vehicles in Q1, Tesla added. Analysts polled by Bloomberg estimated 452,976. The decline in volume was due to the early phase of the manufacturing ramp of...
AstraZeneca, Daiichi Sankyo Say US FDA Accepts Their Biologics License Application for Breast Cancer Treatment
AstraZeneca, Daiichi Sankyo Say US FDA Accepts Their Biologics License Application for Breast Cancer Treatment
Apr 2, 2024
09:25 AM EDT, 04/02/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Tuesday the US Food and Drug Administration has accepted their Biologics License Application for datopotamab deruxtecan to treat adult patients with unresectable or metastatic hormone receptor breast cancer. Datopotamab deruxtecan, discovered by Daiichi Sankyo, is being jointly developed by Daiichi Sankyo and AstraZeneca ( AZN...
Output drops at Kazakhstan's Kashagan oil field - sources
Output drops at Kazakhstan's Kashagan oil field - sources
Apr 2, 2024
MOSCOW, April 2 (Reuters) - Output at the Kashagan oil field, one of Kazakhstan's largest, fell to 30,342 metric tons on April 1 from 52,390 tons a day earlier, two sources familiar with the data told Reuters on Tuesday. An ecological organisation in Kazakhstan said on Tuesday that a large oil spill had been captured by satellite imagery in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved